Vray 2.30.01 For 3ds Max 2013 X86 VERIFIED
According to a study performed by ViewRay, Inc. (NASDAQ:VRAY) MRI-guided radiation therapy (MRgRT) is more accurate and more effective than existing treatments because it is capable of simultaneously imaging tumors, tracking their position during radiation, and delivering radiation only to the targeted tumor. MRIgRT differs from other radiosurgery devices in that it also allows physicians to precisely deliver a much larger radiation dose to tumors that other treatment systems cannot deliver. ViewRay's MRIdian system is the world's first clinically-deployed MRI-guided radiation therapy (MRgRT) system designed to treat tumors using the unique potential of MRI. MRI-guided radiation therapy (MRgRT) is an advanced form of radiation therapy that uses a special MRI-guided external beam treatment system to deliver a large radiation dose to tumors. MRI-guided radiation therapy can be particularly effective for tumors that are located deep within the body or are located adjacent to the intestines or other sensitive organs. MRIdian is also designed to give radiologists and radiation oncologists the ability to customize the treatment for each tumor location, and it incorporates state-of-the-art imaging and target registration technology to help pinpoint the exact location of the tumor and to ensure that the radiation dose is precisely delivered. Our MRIdian system integrates the MRI imaging capability of the world's first MRI-guided radiation therapy system into a more compact, versatile, and cost-effective system, enabling physicians to provide more cost effective and thorough cancer treatment.
Vray 2.30.01 For 3ds Max 2013 X86